[DPHARMA] YoY TTM Result on 30-Jun-2022 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Jun-2022 [#2]
Profit Trend
QoQ- 1.35%
YoY- 9.41%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 697,025 684,965 589,751 582,654 537,324 484,882 394,690 9.93%
PBT 81,539 87,730 82,412 70,825 70,598 53,202 38,579 13.27%
Tax -12,855 -18,449 -19,088 -15,643 -15,562 -9,321 -3,626 23.47%
NP 68,684 69,281 63,324 55,182 55,036 43,881 34,953 11.91%
-
NP to SH 68,684 69,281 63,324 55,182 55,036 44,396 35,484 11.63%
-
Tax Rate 15.77% 21.03% 23.16% 22.09% 22.04% 17.52% 9.40% -
Total Cost 628,341 615,684 526,427 527,472 482,288 441,001 359,737 9.73%
-
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div 21,929 21,685 45,892 37,536 33,094 20,937 7,085 20.70%
Div Payout % 31.93% 31.30% 72.47% 68.02% 60.13% 47.16% 19.97% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth 670,448 634,375 614,350 581,725 503,029 209,983 463,071 6.35%
NOSH 961,942 952,239 706,330 684,383 661,881 650,902 278,959 22.90%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 9.85% 10.11% 10.74% 9.47% 10.24% 9.05% 8.86% -
ROE 10.24% 10.92% 10.31% 9.49% 10.94% 21.14% 7.66% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 72.77 72.34 83.52 85.14 81.18 173.19 141.49 -10.48%
EPS 7.17 7.32 8.97 8.06 8.32 15.86 12.72 -9.10%
DPS 2.30 2.30 6.50 5.50 5.00 7.50 2.54 -1.63%
NAPS 0.70 0.67 0.87 0.85 0.76 0.75 1.66 -13.39%
Adjusted Per Share Value based on latest NOSH - 952,239
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 72.46 71.21 61.31 60.57 55.86 50.41 41.03 9.93%
EPS 7.14 7.20 6.58 5.74 5.72 4.62 3.69 11.62%
DPS 2.28 2.25 4.77 3.90 3.44 2.18 0.74 20.61%
NAPS 0.697 0.6595 0.6387 0.6047 0.5229 0.2183 0.4814 6.35%
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 1.30 1.20 3.03 1.62 1.37 1.30 2.25 -
P/RPS 1.79 1.66 3.63 1.90 1.69 0.75 1.59 1.99%
P/EPS 18.13 16.40 33.79 20.09 16.48 8.20 17.69 0.41%
EY 5.52 6.10 2.96 4.98 6.07 12.20 5.65 -0.38%
DY 1.77 1.92 2.15 3.40 3.65 5.77 1.13 7.76%
P/NAPS 1.86 1.79 3.48 1.91 1.80 1.73 1.36 5.35%
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 -
Price 1.19 1.34 2.49 3.15 1.41 1.08 2.03 -
P/RPS 1.64 1.85 2.98 3.70 1.74 0.62 1.43 2.30%
P/EPS 16.59 18.31 27.77 39.07 16.96 6.81 15.96 0.64%
EY 6.03 5.46 3.60 2.56 5.90 14.68 6.27 -0.64%
DY 1.93 1.72 2.61 1.75 3.55 6.94 1.25 7.50%
P/NAPS 1.70 2.00 2.86 3.71 1.86 1.44 1.22 5.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment